{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:06:36Z","timestamp":1790514396774,"version":"4.1.0"},"reference-count":189,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008714","name":"Motor Neurone Disease Research Institute of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008714","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1105420"],"award-info":[{"award-number":["APP1105420"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.smim.2019.101340","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T09:11:25Z","timestamp":1573117885000},"page":"101340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":127,"special_numbering":"C","title":["Complement dysregulation in the central nervous system during development and disease"],"prefix":"10.1016","volume":"45","author":[{"given":"John D.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam G.","family":"Coulthard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trent M.","family":"Woodruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.smim.2019.101340_bib0005","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.it.2006.06.003","article-title":"TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity","volume":"27","author":"Creagh","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.smim.2019.101340_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2017.00001","article-title":"Keeping it all going-complement meets metabolism","volume":"8","author":"Kolev","year":"2017","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.smim.2019.101340_bib0015","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nri3761","article-title":"Complement--tapping into new sites and effector systems","volume":"14","author":"Kolev","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0020","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2016.08.003","article-title":"Complement-mediated regulation of metabolism and basic cellular processes","volume":"45","author":"Hess","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2019.101340_bib0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-019-0168-x","article-title":"New insights into the immune functions of complement","author":"Reis","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/10454411950060020301","article-title":"Complement biosynthesis in the central nervous system","volume":"6","author":"Barnum","year":"1995","journal-title":"Crit. Rev. Oral Biol. Med."},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0035","first-page":"31","article-title":"Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system","volume":"150","author":"Gasque","year":"1997","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.smim.2019.101340_bib0040","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.4049\/jimmunol.166.6.4154","article-title":"Neuronal expression of a functional receptor for the C5a complement activation fragment","volume":"166","author":"O\u2019Barr","year":"2001","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.smim.2019.101340_bib0045","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2019.101340_bib0050","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.smim.2016.03.015","article-title":"Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions","volume":"28","author":"Brennan","year":"2016","journal-title":"Semin. Immunol."},{"issue":"7","key":"10.1016\/j.smim.2019.101340_bib0055","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.4049\/jimmunol.1203072","article-title":"C5a receptor signaling prevents folate deficiency-induced neural tube defects in mice","volume":"190","author":"Denny","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0060","first-page":"19","article-title":"Complement C3 expression is decreased in autism Spectrum disorder subjects and contributes to behavioral deficits in rodents","volume":"3","author":"Fagan","year":"2017","journal-title":"Mol. Neuropsychiatry"},{"key":"10.1016\/j.smim.2019.101340_bib0065","doi-asserted-by":"crossref","first-page":"15096","DOI":"10.1038\/ncomms15096","article-title":"Developmental activities of the complement pathway in migrating neurons","volume":"8","author":"Gorelik","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00281-017-0662-9","article-title":"Complement in the pathogenesis of Alzheimer\u2019s disease","volume":"40","author":"Morgan","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.smim.2019.101340_bib0075","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nbd.2019.03.003","article-title":"Revisiting the role of the innate immune complement system in ALS","volume":"127","author":"Parker","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.smim.2019.101340_bib0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng.757","article-title":"Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome","volume":"43","author":"Rooryck","year":"2011","journal-title":"Nat. Genet."},{"issue":"7589","key":"10.1016\/j.smim.2019.101340_bib0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature16549","article-title":"Schizophrenia risk from complex variation of complement component 4","volume":"530","author":"Sekar","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.smim.2019.101340_bib0090","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/NDT.S132108","article-title":"Influence of CFH gene on symptom severity of schizophrenia","volume":"13","author":"Zhang","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.smim.2019.101340_bib0095","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.smim.2018.02.009","article-title":"Complement in stem cells and development","volume":"37","author":"Hawksworth","year":"2018","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.smim.2019.101340_bib0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molimm.2016.11.010","article-title":"Complement in the fundamental processes of the cell","volume":"84","author":"Hawksworth","year":"2017","journal-title":"Mol. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2019.101340_bib0105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tins.2018.03.009","article-title":"Complement: The Emerging Architect of the Developing Brain","volume":"41","author":"Coulthard","year":"2018","journal-title":"Trends Neurosci."},{"issue":"2 Pt A","key":"10.1016\/j.smim.2019.101340_bib0110","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.molimm.2015.09.004","article-title":"Co-ordinated expression of innate immune molecules during mouse neurulation","volume":"68","author":"Jeanes","year":"2015","journal-title":"Mol. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2019.101340_bib0115","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1387\/ijdb.072465v","article-title":"Expression of complement components coincides with early patterning and organogenesis in Xenopus laevis","volume":"52","author":"McLin","year":"2008","journal-title":"Int. J. Dev. Biol."},{"issue":"1\u20132","key":"10.1016\/j.smim.2019.101340_bib0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0165-3806(94)90101-5","article-title":"Expression of complement C1qB and C4 mRNAs during rat brain development","volume":"80","author":"Johnson","year":"1994","journal-title":"Brain Res. Dev. Brain Res."},{"issue":"9","key":"10.1016\/j.smim.2019.101340_bib0125","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0166-2236(98)01390-3","article-title":"Complement anaphylatoxin receptors on neurons: new tricks for old receptors?","volume":"22","author":"Nataf","year":"1999","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12017-009-8085-y","article-title":"The role of the complement system and the activation fragment C5a in the central nervous system","volume":"12","author":"Woodruff","year":"2010","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.smim.2019.101340_bib0135","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.molimm.2018.06.271","article-title":"Complement C3a receptor modulates embryonic neural progenitor cell proliferation and cognitive performance","volume":"101","author":"Coulthard","year":"2018","journal-title":"Mol. Immunol."},{"issue":"22","key":"10.1016\/j.smim.2019.101340_bib0140","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1523\/JNEUROSCI.0525-17.2017","article-title":"Complement C5aR1 signaling promotes polarization and proliferation of embryonic neural progenitor cells through PKCzeta","volume":"37","author":"Coulthard","year":"2017","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.smim.2019.101340_bib0145","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1002\/stem.1801","article-title":"Brief report: complement C5a promotes human embryonic stem cell pluripotency in the absence of FGF2","volume":"32","author":"Hawksworth","year":"2014","journal-title":"Stem Cells"},{"issue":"17","key":"10.1016\/j.smim.2019.101340_bib0150","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1073\/pnas.0913449107","article-title":"Enhanced synaptic connectivity and epilepsy in C1q knockout mice","volume":"107","author":"Chu","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.smim.2019.101340_bib0155","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.devcel.2011.10.012","article-title":"Complement fragment C3a controls mutual cell attraction during collective cell migration","volume":"21","author":"Carmona-Fontaine","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.smim.2019.101340_bib0160","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fncel.2017.00169","article-title":"Serping1\/C1 inhibitor affects cortical development in a cell autonomous and non-cell autonomous manner","volume":"11","author":"Gorelik","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.smim.2019.101340_bib0165","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fnmol.2018.00150","article-title":"Complement C3 affects Rac1 activity in the developing brain","volume":"11","author":"Gorelik","year":"2018","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/path.2643","article-title":"Genetics and development of neural tube defects","volume":"220","author":"Copp","year":"2010","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.smim.2019.101340_bib0175","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/14767050500072722","article-title":"Normal pregnancy is characterized by systemic activation of the complement system","volume":"17","author":"Richani","year":"2005","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"issue":"5","key":"10.1016\/j.smim.2019.101340_bib0180","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pt.2013.03.005","article-title":"The impact of placental malaria on neurodevelopment of exposed infants: a role for the complement system?","volume":"29","author":"McDonald","year":"2013","journal-title":"Trends Parasitol."},{"issue":"9","key":"10.1016\/j.smim.2019.101340_bib0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005140","article-title":"Experimental malaria in pregnancy induces neurocognitive injury in uninfected offspring via a C5a-C5a receptor dependent pathway","volume":"11","author":"McDonald","year":"2015","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0190","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/13803390902881918","article-title":"Persistent neuropsychological impairment associated with West Nile virus infection","volume":"32","author":"Sadek","year":"2010","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"7608","key":"10.1016\/j.smim.2019.101340_bib0195","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature18283","article-title":"A complement-microglial axis drives synapse loss during virus-induced memory impairment","volume":"534","author":"Vasek","year":"2016","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.smim.2019.101340_bib0200","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1159\/000489654","article-title":"Association between polymorphisms of the complement 3 gene and schizophrenia in a han chinese population","volume":"46","author":"Zhang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.smim.2019.101340_bib0205","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/npp.2017.164","article-title":"Complement gene expression correlates with superior frontal cortical thickness in humans","volume":"43","author":"Allswede","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.smim.2019.101340_bib0210","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1017\/S0954579418000317","article-title":"Prenatal inflammation and risk for schizophrenia: a role for immune proteins in neurodevelopment","volume":"30","author":"Allswede","year":"2018","journal-title":"Dev. Psychopathol."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0215","doi-asserted-by":"crossref","first-page":"e1024","DOI":"10.1038\/tp.2016.278","article-title":"Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization","volume":"7","author":"Howes","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0220","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.schres.2014.07.053","article-title":"Maternal complement C1q and increased odds for psychosis in adult offspring","volume":"159","author":"Severance","year":"2014","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.smim.2019.101340_bib0225","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000441085","article-title":"GBD 2013 Writing Group, GBD 2013 Stroke Panel Experts Group, Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study","volume":"45","author":"Feigin","year":"2015","journal-title":"Neuroepidemiology"},{"issue":"3","key":"10.1016\/j.smim.2019.101340_bib0230","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pathophys.2009.12.001","article-title":"Pathophysiologic mechanisms of acute ischemic stroke: an overview with emphasis on therapeutic significance beyond thrombolysis","volume":"17","author":"Deb","year":"2010","journal-title":"Pathophysiology"},{"key":"10.1016\/j.smim.2019.101340_bib0235","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12974-015-0464-8","article-title":"Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement","volume":"12","author":"Alawieh","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0240","doi-asserted-by":"crossref","first-page":"429","DOI":"10.14336\/AD.2019.0119","article-title":"Significance of complement system in ischemic stroke: a comprehensive review","volume":"10","author":"Ma","year":"2019","journal-title":"Aging Dis."},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0245","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2008.07.044","article-title":"Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes","volume":"204","author":"Szeplaki","year":"2009","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1227\/01.neu.0000243280.75920.f4","article-title":"Alterations in plasma complement levels after human ischemic stroke","volume":"59","author":"Mocco","year":"2006","journal-title":"Neurosurgery"},{"issue":"6","key":"10.1016\/j.smim.2019.101340_bib0255","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-3083.2009.02253.x","article-title":"In situ deposition of complement in human acute brain ischaemia","volume":"69","author":"Pedersen","year":"2009","journal-title":"Scand. J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0260","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1006\/exnr.1999.7273","article-title":"Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse","volume":"161","author":"Van Beek","year":"2000","journal-title":"Exp. Neurol."},{"issue":"8","key":"10.1016\/j.smim.2019.101340_bib0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072133","article-title":"Cardioembolic and small vessel disease stroke show differences in associations between systemic C3 levels and outcome","volume":"8","author":"Stokowska","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0270","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2249.2004.02489.x","article-title":"Systemic complement activation following human acute ischaemic stroke","volume":"137","author":"Pedersen","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2019.101340_bib0275","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.410400408","article-title":"Complement activation in the central nervous system following blood-brain barrier damage in man","volume":"40","author":"Lindsberg","year":"1996","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.smim.2019.101340_bib0280","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/jnr.20775","article-title":"Temporal pattern of C1q deposition after transient focal cerebral ischemia","volume":"83","author":"Mack","year":"2006","journal-title":"J. Neurosci. Res."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0285","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.WCB.0000046146.31247.A1","article-title":"Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia","volume":"23","author":"De Simoni","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0290","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/01.RES.0000232544.90675.42","article-title":"Complement component C3 mediates inflammatory injury following focal cerebral ischemia","volume":"99","author":"Mocco","year":"2006","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.smim.2019.101340_bib0295","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0002-9440(10)63744-3","article-title":"The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q","volume":"164","author":"De Simoni","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0300","doi-asserted-by":"crossref","first-page":"e8433","DOI":"10.1371\/journal.pone.0008433","article-title":"Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke","volume":"5","author":"Cervera","year":"2010","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.smim.2019.101340_bib0305","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1161\/CIRCULATIONAHA.112.103051","article-title":"Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia","volume":"126","author":"Orsini","year":"2012","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.smim.2019.101340_bib0310","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.4049\/jimmunol.1201904","article-title":"The alternative complement pathway propagates inflammation and injury in murine ischemic stroke","volume":"189","author":"Elvington","year":"2012","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2019.101340_bib0315","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.4049\/jimmunol.181.11.8068","article-title":"A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia\/reperfusion injury","volume":"181","author":"Huang","year":"2008","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0320","doi-asserted-by":"crossref","first-page":"788","DOI":"10.4049\/jimmunol.1502287","article-title":"Intracellular activation of complement 3 is responsible for intestinal tissue damage during mesenteric ischemia","volume":"198","author":"Satyam","year":"2017","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2019.101340_bib0325","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/jnc.12111","article-title":"Complement component 3 inhibition by an antioxidant is neuroprotective after cerebral ischemia and reperfusion in mice","volume":"124","author":"Yang","year":"2013","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.smim.2019.101340_bib0330","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.4049\/jimmunol.177.10.7266","article-title":"Complement-dependent P-selectin expression and injury following ischemic stroke","volume":"177","author":"Atkinson","year":"2006","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2019.101340_bib0335","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s12975-011-0104-2","article-title":"The neuroprotective effect of genetic mannose-binding lectin deficiency is not sustained in the sub-acute phase of stroke","volume":"2","author":"Ducruet","year":"2011","journal-title":"Transl. Stroke Res."},{"issue":"6","key":"10.1016\/j.smim.2019.101340_bib0340","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/sj.emboj.7601004","article-title":"Complement: a novel factor in basal and ischemia-induced neurogenesis","volume":"25","author":"Rahpeymai","year":"2006","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0345","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/glia.10069","article-title":"Expression of the complement C3a and C5a receptors after permanent focal ischemia: an alternative interpretation","volume":"38","author":"Barnum","year":"2002","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.smim.2019.101340_bib0350","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/sj.jcbfm.9600608","article-title":"C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent","volume":"28","author":"Ducruet","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0355","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/brain\/aww314","article-title":"Complement peptide C3a stimulates neural plasticity after experimental brain ischaemia","volume":"140","author":"Stokowska","year":"2017","journal-title":"Brain"},{"issue":"35","key":"10.1016\/j.smim.2019.101340_bib0360","doi-asserted-by":"crossref","first-page":"14104","DOI":"10.1073\/pnas.0700506104","article-title":"Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death","volume":"104","author":"Arumugam","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0365","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1227\/01.NEU.0000335079.70222.8D","article-title":"Protective effect of C5a receptor inhibition after murine reperfused stroke","volume":"63","author":"Kim","year":"2008","journal-title":"Neurosurgery"},{"issue":"9","key":"10.1016\/j.smim.2019.101340_bib0370","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1096\/fj.11-202382","article-title":"Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis","volume":"26","author":"Pavlovski","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2019.101340_bib0375","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-7-15","article-title":"Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice","volume":"7","author":"Harhausen","year":"2010","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0380","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12974-018-1066-z","article-title":"The role of the complement system in traumatic brain injury: a review","volume":"15","author":"Hammad","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"12","key":"10.1016\/j.smim.2019.101340_bib0385","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1089\/08977150152725605","article-title":"Complement activation in the human brain after traumatic head injury","volume":"18","author":"Bellander","year":"2001","journal-title":"J. Neurotrauma"},{"issue":"1\u20132","key":"10.1016\/j.smim.2019.101340_bib0390","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0165-5728(96)00164-6","article-title":"Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injury","volume":"73","author":"Kossmann","year":"1997","journal-title":"J. Neuroimmunol."},{"issue":"8","key":"10.1016\/j.smim.2019.101340_bib0395","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1089\/089771501316919139","article-title":"Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury","volume":"18","author":"Stahel","year":"2001","journal-title":"J. Neurotrauma"},{"issue":"8","key":"10.1016\/j.smim.2019.101340_bib0400","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1097\/CCM.0000000000000399","article-title":"Mannose-binding lectin is expressed after clinical and experimental traumatic brain injury and its deletion is protective","volume":"42","author":"Longhi","year":"2014","journal-title":"Crit. Care Med."},{"issue":"5","key":"10.1016\/j.smim.2019.101340_bib0405","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/jcbfm.1995.107","article-title":"Effect of soluble complement receptor-1 on neutrophil accumulation after traumatic brain injury in rats","volume":"15","author":"Kaczorowski","year":"1995","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"9","key":"10.1016\/j.smim.2019.101340_bib0410","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/01.WCB.0000084250.20114.2C","article-title":"Central nervous system-targeted complement inhibition mediates neuroprotection after closed head injury in transgenic mice","volume":"23","author":"Rancan","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0415","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.expneurol.2006.01.033","article-title":"Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury","volume":"199","author":"Leinhase","year":"2006","journal-title":"Exp. Neurol."},{"issue":"12","key":"10.1016\/j.smim.2019.101340_bib0420","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/sj.jcbfm.9600497","article-title":"Reduced tissue damage and improved recovery of motor function after traumatic brain injury in mice deficient in complement component C4","volume":"27","author":"You","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0425","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/CCM.0b013e318195998a","article-title":"C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice","volume":"37","author":"Longhi","year":"2009","journal-title":"Crit. Care Med."},{"issue":"1\u20132","key":"10.1016\/j.smim.2019.101340_bib0430","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jneuroim.2004.06.003","article-title":"Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist","volume":"155","author":"Sewell","year":"2004","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.smim.2019.101340_bib0435","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/sj.jcbfm.9600605","article-title":"Mannose binding lectin gene deficiency increases susceptibility to traumatic brain injury in mice","volume":"28","author":"Yager","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.smim.2019.101340_bib0440","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2202-7-55","article-title":"Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation","volume":"7","author":"Leinhase","year":"2006","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.smim.2019.101340_bib0445","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1742-2094-4-13","article-title":"Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice","volume":"4","author":"Leinhase","year":"2007","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.smim.2019.101340_bib0450","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.4049\/jimmunol.1302793","article-title":"Inhibition of the membrane attack complex of the complement system reduces secondary neuroaxonal loss and promotes neurologic recovery after traumatic brain injury in mice","volume":"192","author":"Fluiter","year":"2014","journal-title":"J. Immunol."},{"issue":"46","key":"10.1016\/j.smim.2019.101340_bib0455","doi-asserted-by":"crossref","first-page":"14319","DOI":"10.1073\/pnas.1513698112","article-title":"An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice","volume":"112","author":"Ruseva","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.smim.2019.101340_bib0460","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-2094-6-2","article-title":"Absence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in mice","volume":"6","author":"Stahel","year":"2009","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.smim.2019.101340_bib0465","first-page":"335","article-title":"Proteins of the complement system and acute phase reactants in sera of patients with spinal cord injury","volume":"66","author":"Rebhun","year":"1991","journal-title":"Ann. Allergy"},{"issue":"12","key":"10.1016\/j.smim.2019.101340_bib0470","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1089\/neu.2004.21.1831","article-title":"Activation of complement pathways after contusion-induced spinal cord injury","volume":"21","author":"Anderson","year":"2004","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0475","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0306-4522(95)00103-P","article-title":"Complement and clusterin in the spinal cord dorsal horn and gracile nucleus following sciatic nerve injury in the adult rat","volume":"68","author":"Liu","year":"1995","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.smim.2019.101340_bib0480","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2353\/ajpath.2006.060248","article-title":"Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma","volume":"169","author":"Qiao","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.smim.2019.101340_bib0485","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1089\/neu.2005.22.382","article-title":"Upregulation of complement inhibitors in association with vulnerable cells following contusion-induced spinal cord injury","volume":"22","author":"Anderson","year":"2005","journal-title":"J. Neurotrauma"},{"issue":"51","key":"10.1016\/j.smim.2019.101340_bib0490","doi-asserted-by":"crossref","first-page":"13876","DOI":"10.1523\/JNEUROSCI.2823-08.2008","article-title":"Deficiency in complement C1q improves histological and functional locomotor outcome after spinal cord injury","volume":"28","author":"Galvan","year":"2008","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.smim.2019.101340_bib0495","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.2353\/ajpath.2010.100158","article-title":"The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury","volume":"177","author":"Qiao","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0500","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sc.2009.104","article-title":"Soluble complement receptor type 1 inhibits complement system activation and improves motor function in acute spinal cord injury","volume":"48","author":"Li","year":"2010","journal-title":"Spinal Cord"},{"issue":"Pt 2","key":"10.1016\/j.smim.2019.101340_bib0505","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/brain\/awp322","article-title":"Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment","volume":"133","author":"Beck","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.smim.2019.101340_bib0510","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2014.02.008","article-title":"Complement C5a is detrimental to histological and functional locomotor recovery after spinal cord injury in mice","volume":"66","author":"Li","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"16","key":"10.1016\/j.smim.2019.101340_bib0515","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1523\/JNEUROSCI.5218-14.2015","article-title":"The complement receptor C5aR controls acute inflammation and astrogliosis following spinal cord injury","volume":"35","author":"Brennan","year":"2015","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.smim.2019.101340_bib0520","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1089\/neu.2016.4701","article-title":"The alternative receptor for complement component 5a, C5aR2, conveys neuroprotection in traumatic spinal cord injury","volume":"34","author":"Biggins","year":"2017","journal-title":"J. Neurotrauma"},{"issue":"9","key":"10.1016\/j.smim.2019.101340_bib0525","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98254","article-title":"Complement receptor C3aR1 controls neutrophil mobilization following spinal cord injury through physiological antagonism of CXCR2","volume":"4","author":"Brennan","year":"2019","journal-title":"JCI Insight"},{"issue":"13","key":"10.1016\/j.smim.2019.101340_bib0530","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"10.1016\/j.smim.2019.101340_bib0535","doi-asserted-by":"crossref","first-page":"8729","DOI":"10.1073\/pnas.82.24.8729","article-title":"Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related","volume":"82","author":"Wong","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.smim.2019.101340_bib0540","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00702-012-0797-8","article-title":"Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer\u2019s disease","volume":"119","author":"Daborg","year":"2012","journal-title":"J. Neural Transm. Vienna (Vienna)"},{"issue":"4","key":"10.1016\/j.smim.2019.101340_bib0545","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ajpath.2011.01.006","article-title":"Complement 3 and factor h in human cerebrospinal fluid in Parkinson\u2019s disease, Alzheimer\u2019s disease, and multiple-system atrophy","volume":"178","author":"Wang","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0550","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","article-title":"Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis","volume":"77","author":"Karch","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.smim.2019.101340_bib0555","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.smim.2019.101340_bib0560","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.smim.2019.101340_bib0565","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/BF00687336","article-title":"Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques","volume":"63","author":"Ishii","year":"1984","journal-title":"Acta Neuropathol."},{"issue":"21","key":"10.1016\/j.smim.2019.101340_bib0570","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.1073\/pnas.89.21.10016","article-title":"Complement activation by beta-amyloid in Alzheimer disease","volume":"89","author":"Rogers","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.smim.2019.101340_bib0575","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/BF00192116","article-title":"Complement activation in amyloid plaques in Alzheimer\u2019s disease brains does not proceed further than C3","volume":"426","author":"Veerhuis","year":"1995","journal-title":"Virchows Arch."},{"key":"10.1016\/j.smim.2019.101340_bib0580","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1742-2094-10-25","article-title":"Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology","volume":"10","author":"Fonseca","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.smim.2019.101340_bib0585","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0197-4580(97)00042-0","article-title":"Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer\u2019s disease","volume":"18","author":"Webster","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.smim.2019.101340_bib0590","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1742-2094-9-179","article-title":"Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study","volume":"9","author":"Cribbs","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"20","key":"10.1016\/j.smim.2019.101340_bib0595","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1523\/JNEUROSCI.20-20-07505.2000","article-title":"Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer\u2019s disease","volume":"20","author":"Yang","year":"2000","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.smim.2019.101340_bib0600","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41591-018-0336-8","article-title":"ApoE attenuates unresolvable inflammation by complex formation with activated C1q","volume":"25","author":"Yin","year":"2019","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.smim.2019.101340_bib0605","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0002-9440(10)64085-0","article-title":"Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer\u2019s disease","volume":"158","author":"Matsuoka","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.smim.2019.101340_bib0610","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0002-9440(10)65340-0","article-title":"Up-regulated production and activation of the complement system in Alzheimer\u2019s disease brain","volume":"154","author":"Yasojima","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0615","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1074\/jbc.M112.400168","article-title":"C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-beta neurotoxicity","volume":"288","author":"Benoit","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"29","key":"10.1016\/j.smim.2019.101340_bib0620","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.1523\/JNEUROSCI.0901-04.2004","article-title":"Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer\u2019s disease","volume":"24","author":"Fonseca","year":"2004","journal-title":"J. Neurosci."},{"issue":"6286","key":"10.1016\/j.smim.2019.101340_bib0625","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0630","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1021600212829","article-title":"Increased fibrillar beta-amyloid in response to human clq injections into hippocampus and cortex of APP+PS1 transgenic mice","volume":"28","author":"Boyett","year":"2003","journal-title":"Neurochem. Res."},{"issue":"6","key":"10.1016\/j.smim.2019.101340_bib0635","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.neuron.2018.10.014","article-title":"Changes in the synaptic proteome in Tauopathy and rescue of tau-induced synapse loss by C1q antibodies","volume":"100","author":"Dejanovic","year":"2018","journal-title":"Neuron"},{"issue":"25","key":"10.1016\/j.smim.2019.101340_bib0640","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1523\/JNEUROSCI.0829-08.2008","article-title":"Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia\/macrophage phenotype in amyloid precursor protein transgenic mice","volume":"28","author":"Maier","year":"2008","journal-title":"J. Neurosci."},{"issue":"392","key":"10.1016\/j.smim.2019.101340_bib0645","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6295","article-title":"Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice","volume":"9","author":"Shi","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0650","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuron.2014.11.018","article-title":"NFkappaB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer\u2019s disease","volume":"85","author":"Lian","year":"2015","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.smim.2019.101340_bib0655","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.neuron.2018.10.031","article-title":"Complement C3aR inactivation attenuates tau pathology and reverses an immune network deregulated in tauopathy models and alzheimer\u2019s disease","volume":"100","author":"Litvinchuk","year":"2018","journal-title":"Neuron"},{"issue":"16","key":"10.1016\/j.smim.2019.101340_bib0660","doi-asserted-by":"crossref","first-page":"10837","DOI":"10.1073\/pnas.162350199","article-title":"Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer\u2019s mice","volume":"99","author":"Wyss-Coray","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0665","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1471-4159.2010.06595.x","article-title":"Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer\u2019s disease","volume":"113","author":"Ager","year":"2010","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0670","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","article-title":"Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer\u2019s disease","volume":"183","author":"Fonseca","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0675","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13024-017-0210-z","article-title":"Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss","volume":"12","author":"Hernandez","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0680","doi-asserted-by":"crossref","DOI":"10.1177\/1759091416687871","article-title":"C5a increases the injury to primary neurons elicited by fibrillar amyloid Beta","volume":"9","author":"Hernandez","year":"2017","journal-title":"ASN Neuro"},{"key":"10.1016\/j.smim.2019.101340_bib0685","doi-asserted-by":"crossref","first-page":"17085","DOI":"10.1038\/nrdp.2017.85","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"16","key":"10.1016\/j.smim.2019.101340_bib0690","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1056\/NEJMc1710379","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2019.101340_bib0695","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/2152-7806.169561","article-title":"A comprehensive review of amyotrophic lateral sclerosis","volume":"6","author":"Zarei","year":"2015","journal-title":"Surg. Neurol. Int."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0700","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-0404.1991.tb04656.x","article-title":"Serum and CSF immunological findings in ALS","volume":"83","author":"Apostolski","year":"1991","journal-title":"Acta Neurol. Scand."},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0705","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12974-016-0538-2","article-title":"Troost, Complement activation at the motor end-plates in amyotrophic lateral sclerosis","volume":"13","author":"Bahia El","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.smim.2019.101340_bib0710","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.nbd.2011.01.002","article-title":"Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation","volume":"42","author":"Sta","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0715","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0022-510X(97)00225-6","article-title":"Cerebrospinal fluid complement activation in neurological diseases","volume":"154","author":"Trbojevic-Cepe","year":"1998","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.smim.2019.101340_bib0720","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/jnnp.57.7.859","article-title":"Increased concentration of C4d complement protein in CSF in amyotrophic lateral sclerosis","volume":"57","author":"Tsuboi","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0725","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0404.1994.tb01631.x","article-title":"Increased concentration of C4d complement protein in the cerebrospinal fluids in progressive supranuclear palsy","volume":"89","author":"Yamada","year":"1994","journal-title":"Acta Neurol. Scand."},{"issue":"1\u20132","key":"10.1016\/j.smim.2019.101340_bib0730","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jneuroim.2014.09.005","article-title":"Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood","volume":"276","author":"Mantovani","year":"2014","journal-title":"J. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.smim.2019.101340_bib0735","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jneuroim.2009.01.028","article-title":"The complement factor C5a receptor is upregulated in NFL-\/- mouse motor neurons","volume":"210","author":"Humayun","year":"2009","journal-title":"J. Neuroimmunol."},{"issue":"34","key":"10.1016\/j.smim.2019.101340_bib0740","doi-asserted-by":"crossref","first-page":"9201","DOI":"10.1523\/JNEUROSCI.1470-07.2007","article-title":"Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS","volume":"27","author":"Ferraiuolo","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.smim.2019.101340_bib0745","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2007.05.044","article-title":"Gene expression analysis of the murine model of amyotrophic lateral sclerosis: studies of the Leu126delTT mutation in SOD1","volume":"1160","author":"Fukada","year":"2007","journal-title":"Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.smim.2019.101340_bib0750","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jneuroim.2011.03.011","article-title":"Complement upregulation and activation on motor neurons and neuromuscular junction in the SOD1 G93A mouse model of familial amyotrophic lateral sclerosis","volume":"235","author":"Heurich","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.smim.2019.101340_bib0755","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1742-2094-10-119","article-title":"Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis","volume":"10","author":"Lee","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0760","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12974-018-1217-2","article-title":"Complement components are upregulated and correlate with disease progression in the TDP-43(Q331K) mouse model of amyotrophic lateral sclerosis","volume":"15","author":"Lee","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"18","key":"10.1016\/j.smim.2019.101340_bib0765","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.1073\/pnas.0702230104","article-title":"Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons","volume":"104","author":"Lobsiger","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"46","key":"10.1016\/j.smim.2019.101340_bib0770","doi-asserted-by":"crossref","first-page":"E4385","DOI":"10.1073\/pnas.1318309110","article-title":"C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice","volume":"110","author":"Lobsiger","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.smim.2019.101340_bib0775","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ana.1252","article-title":"Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord","volume":"50","author":"Olsen","year":"2001","journal-title":"Ann. Neurol."},{"issue":"21","key":"10.1016\/j.smim.2019.101340_bib0780","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1093\/hmg\/ddi357","article-title":"No widespread induction of cell death genes occurs in pure motoneurons in an amyotrophic lateral sclerosis mouse model","volume":"14","author":"Perrin","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0785","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13395-017-0128-8","article-title":"Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Wang","year":"2017","journal-title":"Skelet. Muscle"},{"issue":"49","key":"10.1016\/j.smim.2019.101340_bib0790","doi-asserted-by":"crossref","first-page":"20960","DOI":"10.1073\/pnas.0911405106","article-title":"Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice","volume":"106","author":"Chiu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.smim.2019.101340_bib0795","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/bph.13730","article-title":"Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"174","author":"Lee","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0800","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1073\/pnas.1321248111","article-title":"Role for terminal complement activation in amyotrophic lateral sclerosis disease progression","volume":"111","author":"Woodruff","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.smim.2019.101340_bib0805","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.4049\/jimmunol.181.12.8727","article-title":"The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis","volume":"181","author":"Woodruff","year":"2008","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2019.101340_bib0810","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/bph.13730","article-title":"Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"174","author":"Lee","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.smim.2019.101340_bib0815","first-page":"1015","article-title":"Complement component C6 inhibition decreases neurological disability in female transgenic SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"1","author":"Bahia El","year":"2016","journal-title":"Ann Neurodegener Dis"},{"key":"10.1016\/j.smim.2019.101340_bib0820","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/B978-0-12-381328-2.00014-6","article-title":"Genetics and neuropathology of Huntington\u2019s disease","volume":"98","author":"Reiner","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"issue":"6","key":"10.1016\/j.smim.2019.101340_bib0825","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"T.H.s.D.C.R. Group","year":"1993","journal-title":"Cell"},{"issue":"5334","key":"10.1016\/j.smim.2019.101340_bib0830","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.smim.2019.101340_bib0835","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.smim.2019.101340_bib0840","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/541259","article-title":"The role of the immune system in Huntington\u2019s disease","volume":"2013","author":"Ellrichmann","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.smim.2019.101340_bib0845","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/563784","article-title":"Huntington\u2019s disease: an immune perspective","volume":"2011","author":"Nayak","year":"2011","journal-title":"Neurol. Res. Int."},{"issue":"7","key":"10.1016\/j.smim.2019.101340_bib0850","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J. Proteome Res."},{"issue":"10","key":"10.1016\/j.smim.2019.101340_bib0855","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1515\/CCLM.1998.132","article-title":"Activated immune system in patients with Huntington\u2019s disease","volume":"36","author":"Leblhuber","year":"1998","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0860","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/exnr.1999.7170","article-title":"Increased complement biosynthesis by microglia and complement activation on neurons in Huntington\u2019s disease","volume":"159","author":"Singhrao","year":"1999","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.smim.2019.101340_bib0865","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington\u2019s disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.smim.2019.101340_bib0870","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1096\/fj.05-5814com","article-title":"Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration","volume":"20","author":"Woodruff","year":"2006","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0875","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3233\/JHD-2012-120021","article-title":"Genetic deficiency of complement component 3 does not alter disease progression in a mouse model of Huntington\u2019s disease","volume":"1","author":"Larkin","year":"2012","journal-title":"J. Huntingtons Dis."},{"issue":"6","key":"10.1016\/j.smim.2019.101340_bib0880","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"9996","key":"10.1016\/j.smim.2019.101340_bib0885","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"465","key":"10.1016\/j.smim.2019.101340_bib0890","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4066","article-title":"Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice","volume":"10","author":"Gordon","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.smim.2019.101340_bib0895","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","article-title":"Molecular pathophysiology of Parkinson\u2019s disease","volume":"28","author":"Moore","year":"2005","journal-title":"Annu. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.smim.2019.101340_bib0900","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bbrc.2006.02.051","article-title":"Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson\u2019s disease","volume":"342","author":"Goldknopf","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.smim.2019.101340_bib0905","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/NEN.0b013e31820805b9","article-title":"Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease","volume":"70","author":"Depboylu","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.smim.2019.101340_bib0910","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-3-29","article-title":"Complement activation in the Parkinson\u2019s disease substantia nigra: an immunocytochemical study","volume":"3","author":"Loeffler","year":"2006","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.smim.2019.101340_bib0915","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00427222","article-title":"Lewy bodies in Parkinson\u2019s disease are recognized by antibodies to complement proteins","volume":"84","author":"Yamada","year":"1992","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.smim.2019.101340_bib0920","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.bbrc.2007.04.055","article-title":"Complement activation by islet amyloid polypeptide (IAPP) and alpha-synuclein 112","volume":"357","author":"Klegeris","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1\u20132","key":"10.1016\/j.smim.2019.101340_bib0925","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneuroim.2011.05.006","article-title":"Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson disease","volume":"236","author":"Depboylu","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.smim.2019.101340_bib0930","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.brainres.2007.08.033","article-title":"Complement 3-deficient mice are not protected against MPTP-induced dopaminergic neurotoxicity","volume":"1178","author":"Liang","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.smim.2019.101340_bib0935","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.redox.2017.09.017","article-title":"Complement receptor 3 mediates NADPH oxidase activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway","volume":"14","author":"Hou","year":"2018","journal-title":"Redox Biol."},{"issue":"7","key":"10.1016\/j.smim.2019.101340_bib0940","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1084\/jem.20172244","article-title":"Neuronal integrity and complement control synaptic material clearance by microglia after CNS injury","volume":"215","author":"Norris","year":"2018","journal-title":"J. Exp. Med."},{"issue":"26","key":"10.1016\/j.smim.2019.101340_bib0945","doi-asserted-by":"crossref","first-page":"21769","DOI":"10.18632\/oncotarget.4844","article-title":"Complementing regeneration","volume":"6","author":"Alawieh","year":"2015","journal-title":"Oncotarget"}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104453231930020X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104453231930020X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:46:25Z","timestamp":1778795185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104453231930020X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":189,"alternative-id":["S104453231930020X"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2019.101340","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement dysregulation in the central nervous system during development and disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2019.101340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101340"}}